Fresh NIH funding backs an iPSC-and-AI push to f

AstronauTx has exercised its Saniona option, adv

Health-testing company pairs its member data wit

BTT Medical Institute, in collaboration with BTT

Celularity and MuseCell Innovations announced a U

AlzeCure will present at the Pareto Securities 17

Seven months after ditching paper screening for

Oligonucleotide drug slows Alzheimer’s decline

Oura Health is preparing for a potential U.S.

Retro Biosciences is expanding its phase 1 safety

Insilico Medicine released interim results for th

HEALTH survey suggests the longevity conversatio

Anavex reported a business update and financial r

Alnylam will present new clinical and real-world

Eisai and Biogen announced that LEQEMBI IQLIK (le

What if your healthcare could connect the dots b

Self-contracting myografts improved muscle, bone

Self-contracting myografts improved muscle, bone

Icahn School of Medicine wins $1m award as its N

Growth financing will help expand the Syn-One Te

AVLAYAH brought in $3.

AlzeCure collects its upfront payment from Eli L

NRG Therapeutics presented a poster at the ALS As

United Therapeutics announced that the U.S.

Eisai has begun U.S.

Eisai has begun U.S.

Eisai has begun U.S.

Early human data suggest Vandria’s drug candid

A $29 add-on through Quest’s US labs turns rou

AliveCor announced a prospective cohort study (M-

Rznomics is joining Lilly Gateway Labs in San Die

The U.S.

Collagevita’s Medical Director explains why re

Pemvidutide’s balanced glucagon/GLP-1 action h

EHE Health’s partnership with Prenuvo brings b

Niagen Bioscience announced that Tru Niagen is no

Fractyl Health will host a virtual Commercial Str

Mitochon Pharmaceuticals has been awarded a $1 mi

Phase 2a study completes enrollment as biotech t

Corundum Corp’s Maayan Eilon-Ashkenazy explain

FDA accelerates development of XellSmart’s off

Drug mimics a hormone you make when you push har

Cumulus Neuroscience published final results from

Biograph has launched a Women’s Health Program

Wonderfeel ranked No. 1 in biotechnology and No.

Longevica Therapeutics has appointed Dr Prasun Mi

Enveda reported positive Phase 1 results for ENV-

Enzymedica announced the launch of two Phytosome® formulas, Sleep & Stress Lemon Balm Phytosome and Joint & Muscle PEA Phytosome, expanding the brand’s Phytosome collection. The melatonin-free Sleep & Stress product (SRP $24.99, 60 count) is presented as a vegan, non-habit-forming option for day or night use to support relaxation and restful sleep. Joint & Muscle (SRP $24.99, 45 count) is positioned for comfort, mobility and recovery. Enzymedica claims clinical findings for Sleep & Stress included participants reporting three times better sleep and improved mood, and that Joint & Muscle delivered six times better absorption compared to standard micronized PEA. The release states Phytosome technology pairs botanical compounds with phospholipids to improve absorption and bioavailability, and notes the new products join Enzymedica’s existing Berberine Phytosome offerings. The company is based in Venice, Florida. The post Enzymedica launches phytosome formulas for sleep, joint support appeared first on Longevity.Technology.

Greenstone Biosciences has been awarded a Breakth

AlzeCure has received the full USD 10 million upf